Symetis, the Swiss transcatheter aortic valve replacement company that has been taking market share away from the likes of Edwards Lifesciences Corp. and Medtronic PLC in Europe, is expanding into the mitral valve space.
The firm has acquired Middle Peak Medical Inc. (MPM), a US developer of transcatheter technologies for treating mitral valve...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?